4ZZ0
Human GAR transformylase in complex with GAR and (S)-2-(8-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)octanamido)pentanedioic acid (AGF147)
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 4.2.2 |
Synchrotron site | ALS |
Beamline | 4.2.2 |
Temperature [K] | 100 |
Detector technology | CMOS |
Collection date | 2014-08-24 |
Detector | RDI CMOS_8M |
Wavelength(s) | 1.0001 |
Spacegroup name | P 32 2 1 |
Unit cell lengths | 75.240, 75.240, 100.409 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 39.769 - 1.650 |
R-factor | 0.1611 |
Rwork | 0.160 |
R-free | 0.18520 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4X78 |
RMSD bond length | 0.006 |
RMSD bond angle | 1.153 |
Data reduction software | HKL-2000 |
Data scaling software | SCALEPACK |
Phasing software | PHASER (2.5.6) |
Refinement software | PHENIX (phenix.refine 1.9) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 50.000 | 50.000 | 1.680 |
High resolution limit [Å] | 1.650 | 4.480 | 1.650 |
Rmerge | 0.077 | 0.056 | 0.453 |
Rmeas | 0.081 | 0.059 | 0.492 |
Rpim | 0.025 | 0.018 | 0.186 |
Total number of observations | 387613 | ||
Number of reflections | 40099 | ||
<I/σ(I)> | 17.2 | ||
Completeness [%] | 99.8 | 98.5 | 97.7 |
Redundancy | 9.7 | 10.2 | 6.2 |
CC(1/2) | 0.998 | 0.874 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7.5 | 277 | 18 % PEG4000, 2 % PEG400, 0.33 M NaCl |